Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × INDUSTRY × Memantine × Clear all

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Injections 45 Cisplatin 44 Paclitaxel 43 Carboplatin 37 Docetaxel 33 Gemcitabine 32 Capecitabine 29 Drug Therapy 28 pembrolizumab 26 Bevacizumab 21 anlotinib 20 Fluorouracil 20 icotinib 19 Cyclophosphamide 19 Oxaliplatin 16 fludarabine 15 Pemetrexed 15 Irinotecan 14 Cetuximab 13 Leucovorin 12 apatinib 11 Temozolomide 11 Nivolumab 11 Fulvestrant 11 tesetaxel 10 Doxorubicin 10 Trastuzumab 9 Rituximab 9 130-nm albumin-bound paclitaxel 9 camrelizumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04737967 2021-02-04

The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy

Mendel AI

Phase 2/3 Unknown

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡